Role of Ubiquitination and Epigenetics in the Regulation of AhR Signaling in Carcinogenesis and Metastasis: "Albatross Around the Neck" or "Blessing in Disguise"

Overview

Journal Cells

Publisher MDPI

Specialties Biochemistry
Biophysics
Cell Biology
Molecular Biology

Date 2023 Oct 13

PMID 37830596

Authors

Ammad Ahmad Farooqi

Venera Rakhmetova

Gulnara Kapanova

Gulnur Tanbayeva

Akmaral Mussakhanova

Akmaral Abdykulova

Alma-Gul Ryskulova

Affiliations

Soon will be listed here.

Abstract

The molecular mechanisms and signal transduction cascades evoked by the activation of aryl hydrocarbon receptor (AhR) are becoming increasingly understandable. AhR is a ligand-activated transcriptional factor that integrates environmental, dietary and metabolic cues for the pleiotropic regulation of a wide variety of mechanisms. AhR mediates transcriptional programming in a ligand-specific, context-specific and cell-type-specific manner. Pioneering cutting-edge research works have provided fascinating new insights into the mechanistic role of AhR-driven downstream signaling in a wide variety of cancers. AhR ligands derived from food, environmental contaminants and intestinal microbiota strategically activated AhR signaling and regulated multiple stages of cancer. Although AhR has classically been viewed and characterized as a ligand-regulated transcriptional factor, its role as a ubiquitin ligase is fascinating. Accordingly, recent evidence has paradigmatically shifted our understanding and urged researchers to drill down deep into these novel and clinically valuable facets of AhR biology. Our rapidly increasing realization related to AhR-mediated regulation of the ubiquitination and proteasomal degradation of different proteins has started to scratch the surface of intriguing mechanisms. Furthermore, AhR and epigenome dynamics have shown previously unprecedented complexity during multiple stages of cancer progression. AhR not only transcriptionally regulated epigenetic-associated molecules, but also worked with epigenetic-modifying enzymes during cancer progression. In this review, we have summarized the findings obtained not only from cell-culture studies, but also from animal models. Different clinical trials are currently being conducted using AhR inhibitors and PD-1 inhibitors (Pembrolizumab and nivolumab), which confirm the linchpin role of AhR-related mechanistic details in cancer progression. Therefore, further studies are required to develop a better comprehension of the many-sided and "diametrically opposed" roles of AhR in the regulation of carcinogenesis and metastatic spread of cancer cells to the secondary organs.

References

Shi D, Wu X, Jian Y, Wang J, Huang C, Mo S . USP14 promotes tryptophan metabolism and immune suppression by stabilizing IDO1 in colorectal cancer. Nat Commun. 2022; 13(1):5644. PMC: 9513055. DOI: 10.1038/s41467-022-33285-x. View

Lee J, Cho S, Ko S, Ahrmad S, Puga A, Kim K . Regulation of a long noncoding RNA MALAT1 by aryl hydrocarbon receptor in pancreatic cancer cells and tissues. Biochem Biophys Res Commun. 2020; 532(4):563-569. PMC: 7572814. DOI: 10.1016/j.bbrc.2020.08.053. View

Therachiyil L, Hussein O, Uddin S, Korashy H . Regulation of the aryl hydrocarbon receptor in cancer and cancer stem cells of gynecological malignancies: An update on signaling pathways. Semin Cancer Biol. 2022; 86(Pt 3):1186-1202. DOI: 10.1016/j.semcancer.2022.10.003. View

Goode G, Ballard B, Manning H, Freeman M, Kang Y, Eltom S . Knockdown of aberrantly upregulated aryl hydrocarbon receptor reduces tumor growth and metastasis of MDA-MB-231 human breast cancer cell line. Int J Cancer. 2013; 133(12):2769-80. PMC: 3797219. DOI: 10.1002/ijc.28297. View

Xing X, Bi H, Chang A, Zang M, Wang M, Ao X . SUMOylation of AhR modulates its activity and stability through inhibiting its ubiquitination. J Cell Physiol. 2012; 227(12):3812-9. DOI: 10.1002/jcp.24092. View

Welchman R, Gordon C, Mayer R . Ubiquitin and ubiquitin-like proteins as multifunctional signals. Nat Rev Mol Cell Biol. 2005; 6(8):599-609. DOI: 10.1038/nrm1700. View

Tsai C, Li C, Liao P, Chang Y, Cheng Y, Kang J . Aza-PBHA, a potent histone deacetylase inhibitor, inhibits human gastric-cancer cell migration via PKCα-mediated AHR-HDAC interactions. Biochim Biophys Acta Mol Cell Res. 2019; 1867(2):118564. DOI: 10.1016/j.bbamcr.2019.118564. View

Roeven M, Thordardottir S, Kohela A, Maas F, Preijers F, Jansen J . The Aryl Hydrocarbon Receptor Antagonist StemRegenin1 Improves In Vitro Generation of Highly Functional Natural Killer Cells from CD34(+) Hematopoietic Stem and Progenitor Cells. Stem Cells Dev. 2015; 24(24):2886-98. DOI: 10.1089/scd.2014.0597. View

Ma Z, Li Z, Mao Y, Ye J, Liu Z, Wang Y . AhR diminishes the efficacy of chemotherapy via suppressing STING dependent type-I interferon in bladder cancer. Nat Commun. 2023; 14(1):5415. PMC: 10480448. DOI: 10.1038/s41467-023-41218-5. View

10.

Liao W, Lu J, Wang W, Hung C, Sheu C, Huang S . Epigenetic synergism between interleukin-4 and aryl-hydrocarbon receptor in human macrophages. J Mol Med (Berl). 2016; 95(4):395-404. DOI: 10.1007/s00109-016-1493-1. View

11.

Papoutsis A, Borg J, Selmin O, Romagnolo D . BRCA-1 promoter hypermethylation and silencing induced by the aromatic hydrocarbon receptor-ligand TCDD are prevented by resveratrol in MCF-7 cells. J Nutr Biochem. 2011; 23(10):1324-32. DOI: 10.1016/j.jnutbio.2011.08.001. View

12.

Chen Z, Cai A, Zheng H, Huang H, Sun R, Cui X . Carbidopa suppresses prostate cancer via aryl hydrocarbon receptor-mediated ubiquitination and degradation of androgen receptor. Oncogenesis. 2020; 9(5):49. PMC: 7220950. DOI: 10.1038/s41389-020-0236-x. View

13.

Rannug A, Rannug U, Rosenkranz H, Winqvist L, Westerholm R, Agurell E . Certain photooxidized derivatives of tryptophan bind with very high affinity to the Ah receptor and are likely to be endogenous signal substances. J Biol Chem. 1987; 262(32):15422-7. View

14.

Gershman A, Sauria M, Guitart X, Vollger M, Hook P, Hoyt S . Epigenetic patterns in a complete human genome. Science. 2022; 376(6588):eabj5089. PMC: 9170183. DOI: 10.1126/science.abj5089. View

15.

DAmato N, Rogers T, Gordon M, Greene L, Cochrane D, Spoelstra N . A TDO2-AhR signaling axis facilitates anoikis resistance and metastasis in triple-negative breast cancer. Cancer Res. 2015; 75(21):4651-64. PMC: 4631670. DOI: 10.1158/0008-5472.CAN-15-2011. View

16.

Liu Y, Ouyang L, Mao C, Chen Y, Liu N, Chen L . Inhibition of RNF182 mediated by Bap promotes non-small cell lung cancer progression. Front Oncol. 2023; 12:1009508. PMC: 9853554. DOI: 10.3389/fonc.2022.1009508. View

17.

Burbach K, Poland A, Bradfield C . Cloning of the Ah-receptor cDNA reveals a distinctive ligand-activated transcription factor. Proc Natl Acad Sci U S A. 1992; 89(17):8185-9. PMC: 49882. DOI: 10.1073/pnas.89.17.8185. View

18.

Miyazaki T, Chung S, Sakai H, Ohata H, Obata Y, Shiokawa D . Stemness and immune evasion conferred by the TDO2-AHR pathway are associated with liver metastasis of colon cancer. Cancer Sci. 2021; 113(1):170-181. PMC: 8748246. DOI: 10.1111/cas.15182. View

19.

Zhang M, Zhang H, Du X, Gao J, Li C, Shi H . UCHL3 promotes ovarian cancer progression by stabilizing TRAF2 to activate the NF-κB pathway. Oncogene. 2019; 39(2):322-333. DOI: 10.1038/s41388-019-0987-z. View

20.

Fukunaga B, Probst M, Hankinson O . Identification of functional domains of the aryl hydrocarbon receptor. J Biol Chem. 1995; 270(49):29270-8. DOI: 10.1074/jbc.270.49.29270. View